Alerts will be sent to your verified email
Verify Email
GUJINJEC
|
Guj. Inject (Kerala)
|
Veerhealth Care
|
Concord Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.55 % | 2.69 % | 3.38 % |
|
5yr average Equity Multiplier
|
0.11 | 1.31 | 1.86 |
|
5yr Average Asset Turnover Ratio
|
0.45 | 0.54 | 0.9 |
|
5yr Avg Net Profit Margin
|
-175.28 % | 4.02 % | 1.88 % |
|
Price to Book
|
2.98 | 1.3 | 0.89 |
|
P/E
|
29.87 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-14.62 Days | 80.55 Days | 260.53 Days |
|
Inventory Days
|
38.61 Days | 54.84 Days | 138.17 Days |
|
Days Receivable
|
0.0 | 79.49 Days | 144.77 Days |
|
Days Payable
|
156.02 Days | 58.93 Days | 77.93 Days |
|
5yr Average Interest Coverage Ratio
|
298.1 | 208.32 | 1.8 |
|
5yr Avg ROCE
|
2.0 % | 4.25 % | 8.9 % |
|
5yr Avg Operating Profit Margin
|
-279.73 % | 0.98 % | 9.09 % |
|
5 yr average Debt to Equity
|
-0.62 | 0.06 | 0.55 |
|
5yr CAGR Net Profit
|
n/a | 5.08 % | -21.63 % |
|
5yr Average Return on Assets
|
-116.01 % | 2.18 % | 1.77 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 31.5 % | 54.39 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -10.84 % | 5.39 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Guj. Inject (Kerala)
|
Veerhealth Care
|
Concord Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|